ArticleNPJ precision oncology2025

Relapse-free survival in a pediatric patient with recurrent EZH2-mutant melanoma treated with adjuvant tazemetostat.

Erin E Resch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.